Lezack Adam's Form 4 filing
Beta Bionics, Inc. (BBNX) · filed Nov 5, 2025
- Accession no.
- 0002048466-25-000003
- Filed
- Nov 5, 2025
- Trade date
- Oct 31, 2025
- Filing delay
- 5 daysLate
- Rule 10b5-1 plan
- Checked
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market sales total $37.8K. It was filed 5 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Lezack AdamCIK 0002048466 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Oct 31, 2025 | Common Stock | SSaleDisposed | −1,368 | $26.85 | −$36,730.8 | 9,879 | Direct | |
| Oct 31, 2025 | Common Stock | SSaleDisposed | −38 | $27.70 | −$1,052.6 | 9,841 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.